Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID 19 hospitalized meta-analysis

Balcells
  NCT04375098		 RCTEarly convalescent plasma.Deferred Convalescent plasmaCOVID 19 hospitalizedlow
28/30 inconclusive
  • inconclusive 33 % decrease in death or ventilation (PE) with a high degree of certainty due to low risk of bias

COVID 19 all comers meta-analysis

Cai -FAVIPIRAVIR
  ChiCTR2000029600		 NRainterferoninterferonCOVID 19 all comersNA
35/45 uncontrolled
  • [uncontrolled] Chest CT improvement (day 14): 91.4% (32/35)

COVID-19 severe or critically meta-analysis

Joyner
  NCT04338360		 NRaconvalescent plasma treatmentconvalescent plasma treatmentCOVID-19 severe or criticallyserious
515/561 uncontrolled

    PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
    Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).

     

    - About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons